SOPHiA GENETICS is a leader in AI-driven precision medicine based in Lausanne (Switzerland). The company announced the launch of SOPHiA…

At their 19th Innovation Day, the Geneva University Hospitals (HUG) highlighted 16 innovative projects from the hospital and academic sectors,…

ADC Therapeutics SA, a Vaud-based commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), announced that…

The new entity, valued at CHF 1.1 billion, is positioned as a leader in neurotechnology. The transaction is expected to…

The Canton of Vaud, the Lausanne University Hospital (CHUV), the University of Lausanne (UNIL) and the Ludwig Institute for Cancer…

UCB Farchim, the Swiss subsidiary of Belgian biopharmaceutical group UCB, has announced a major new phase of development for its…

HemostOD, a Swiss Health Valley company pioneering the ex vivo manufacturing of donor-free, off-the-shelf universal human blood platelets, announces the…

A new national initiative, NAIPO (National AI Initiative for Precision Oncology), is set to transform cancer care in Switzerland by…

Two Swiss Health Valley startups supported by Fondation pour l’Innovation Technologique (FIT) are tackling some of healthcare’s most pressing challenges:…

The European investment company listed on Euronext Brussels is thereby becoming a major shareholder. These funds will be used to…

BioArk & New Mexico Venture Studios have established a strategic partnership to support startups in life sciences, medtech, and deep…

Two EPFL-based startups: BioLNP Innovation and OneCell Protein, have become the latest recipients of the EPFL Startup Launchpad Ignition grant….